Table 2.
Relationships of and clinical characteristics Min ALCs in patients with hepatocellular carcinoma
| Variables | Min ALCs ≤ 300 (n = 15) | Min ALCs > 300 (n = 41) | P value |
|---|---|---|---|
| Age (years, median, range) | 57 (34–84) | 60 (46–79) | 0.239 |
| Gender (male/female) | 13/2 | 33/8 | 0.593 |
| KPS (>90/≤80) | 6/9 | 13/28 | 0.562 |
| Hepatitis B virus (+)/(−) | 13/2 | 36/5 | 0.909 |
| Stagea | |||
| II | 1 | 12 | |
| III or IV | 14 | 29 | 0.076 |
Min ALC minimum absolute lymphocyte counts during radiotherapy
aAmerican Joint Committee on Cancer staging manual, seventh edition. Frequency (percent proportions) are shown for all categorical variables and Medians (range) are shown for all continuous variables